Active Substance & Generic Molecule Directory

Dexmedetomidine Hydrochloride in Malaysia: Registered Brands, Dosages & Price Comparison

Directory of all approved pharmaceutical brands containing Dexmedetomidine Hydrochloride registered with the National Pharmaceutical Regulatory Agency (NPRA) / Ministry of Health Malaysia (KKM).

9
Registered Brands
Availability in Malaysia:9 Prescription (MAL-A)
Showing 9 of 9 registered brands
MAL Reg NoBrand Formulation NameStrength / DosageClassificationRegistration HolderAction
MAL24056001AZDexdor 100 micrograms/ml concentrate for solution for infusion118 mcg/mLPrescription (MAL-A)ORION PHARMA (MY) SDN. BHD.Compare →
MAL25056018AZDEXMAIN (Dexmedetomidine 100 mcg/mL Concentrated for Solution for Infusion)0.0118 %w/vPrescription (MAL-A)AIN MEDICARE SDN. BHD.Compare →
MAL24036033AZDexmedetomidine EVER Pharma 200 µg/2ml Concentrate for solution for infusion0.1182 mg/mLPrescription (MAL-A)DIMENSISS HEALTHCARE SDN. BHD.Compare →
MAL25046026AZDexmedetomidine Fresenius 100 mcg/ml Concentrate for Solution for Infusion0.118 mg/mLPrescription (MAL-A)FRESENIUS KABI MALAYSIA SDN. BHDCompare →
MAL17065012ACRZDexmedetomidine Kabi 0.1mg/mL Concentrate for Infusion0.118mg/ml 0Prescription (MAL-A)FRESENIUS KABI MALAYSIA SDN. BHDCompare →
MAL21036022AZEmidex 100mcg/ml Concentrate for Solution for Infusion236 mcg 2 mlPrescription (MAL-A)NOVUGEN PHARMA SDN. BHD.Compare →
MAL19116033AZHYDEX (Dexmedetomidine Concentrate For Infusion 100mcg/ml, 2 ml vial)118.0 mcg/mLPrescription (MAL-A)ACCORD HEALTHCARE SDN.BHD.Compare →
MAL19106012AZICUNES 100mcg/ml Concentrate for Solution for Infusion118 mcg 1 mlPrescription (MAL-A)AVERROES PHARMACEUTICALS SDN. BHD.Compare →
MAL24086031AZUNIDEX Dexmedetomidine Injection USP Concentrate for Infusion 100 mcg/ml118 mcg/mLPrescription (MAL-A)UNIMED SDN. BHD.Compare →

Generic Bioequivalence & Drug Substitution in Malaysia

Generic medications registered under NPRA contain the identical active pharmaceutical ingredient (API) in identical dosage strength and route of administration as the originator brand. NPRA requires rigorous bioequivalence (BE) studies demonstrating that generic drugs deliver the exact therapeutic effect. Always confirm with your doctor or community pharmacist before switching between prescription brands.